Welcome to LookChem.com Sign In|Join Free
  • or
4-(1,3,4-Oxadiazol-2-yl)pyridine is a pyridine derivative with the molecular formula C7H5N3O, featuring an oxadiazole functional group. This chemical compound is recognized for its unique structure and properties, making it a valuable building block in the synthesis of novel compounds with potential biological activities. It is commonly utilized in medicinal chemistry for the development of pharmaceuticals and agrochemicals.

64001-70-3

Post Buying Request

64001-70-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64001-70-3 Usage

Uses

Used in Medicinal Chemistry:
4-(1,3,4-OXADIAZOL-2-YL)PYRIDINE is used as a building block for the development of pharmaceuticals and agrochemicals due to its unique structure and properties that contribute to the synthesis of novel compounds with potential biological activities.
Used in Biological Imaging and Analytical Chemistry:
4-(1,3,4-OXADIAZOL-2-YL)PYRIDINE is used as a fluorescent probe in biological imaging and analytical chemistry applications, capitalizing on its potential to enhance imaging techniques and analytical processes in these fields.
Used in Chemistry, Biology, and Materials Science:
4-(1,3,4-OXADIAZOL-2-YL)PYRIDINE is employed across various applications in the fields of chemistry, biology, and materials science, owing to its promising properties and potential for the development of innovative products and technologies.

Check Digit Verification of cas no

The CAS Registry Mumber 64001-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,0,0 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 64001-70:
(7*6)+(6*4)+(5*0)+(4*0)+(3*1)+(2*7)+(1*0)=83
83 % 10 = 3
So 64001-70-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O/c1-3-8-4-2-6(1)7-10-9-5-11-7/h1-5H

64001-70-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-pyridin-4-yl-1,3,4-oxadiazole

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64001-70-3 SDS

64001-70-3Downstream Products

64001-70-3Relevant academic research and scientific papers

Direct Annulation of Hydrazides to 1,3,4-Oxadiazoles via Oxidative C(CO)-C(Methyl) Bond Cleavage of Methyl Ketones

Gao, Qinghe,Liu, Shan,Wu, Xia,Zhang, Jingjing,Wu, Anxin

supporting information, p. 2960 - 2963 (2015/06/30)

A new strategy for the synthesis of 1,3,4-oxadiazoles was established through direct annulation of hydrazides with methyl ketones. It was found that the use of K2CO3 as a base achieves an unexpected and highly efficient C-C bond clea

Greener and rapid access to bio-active heterocycles: one-pot solvent-free synthesis of 1,3,4-oxadiazoles and 1,3,4-thiadiazoles

Polshettiwar, Vivek,Varma, Rajender S.

, p. 879 - 883 (2008/09/17)

A novel one-pot solvent-free synthesis of 1,3,4-oxadiazoles and 1,3,4-thiadiazoles by condensation of acid hydrazide and triethyl orthoalkanates under microwave irradiations is reported. This green protocol was catalyzed efficiently by solid supported NafionNR50 and phosphorus pentasulfide in alumina (P4S10/Al2O3) with excellent yields.

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 55-56, (2010/02/11)

The application is directed to haloalkyl-substituted compounds of Formula (I), wherein R1, R1a, R2, R3, R4’ and E are as defined in the claims. The compounds are inhibitors of cysteine proteases, in p

AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page/Page column 53, (2010/02/09)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceu

Novel compounds and compositions as cathepsin S inhibitors

-

, (2008/06/13)

The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

PEPTIDIC COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

-

Page 76, (2010/11/30)

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 64001-70-3